These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28826520)

  • 1. Small Molecule PET Tracers in Drug Discovery.
    Donnelly DJ
    Semin Nucl Med; 2017 Sep; 47(5):454-460. PubMed ID: 28826520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in CNS drug discovery and drug monitoring.
    Piel M; Vernaleken I; Rösch F
    J Med Chem; 2014 Nov; 57(22):9232-58. PubMed ID: 25144329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emitting tracers in pre-clinical drug development.
    Fernandes E; Barbosa Z; Clemente G; Alves F; Abrunhosa AJ
    Curr Radiopharm; 2012 Apr; 5(2):90-8. PubMed ID: 22280107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of carbon-11 labelled tool compounds in support of drug development.
    Boscutti G; Huiban M; Passchier J
    Drug Discov Today Technol; 2017 Nov; 25():3-10. PubMed ID: 29233265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks.
    Dupont AC; Arlicot N; Vercouillie J; Serrière S; Maia S; Bonnet-Brilhault F; Santiago-Ribeiro MJ
    Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in Central Nervous System Drug Discovery.
    Gunn RN; Rabiner EA
    Semin Nucl Med; 2017 Jan; 47(1):89-98. PubMed ID: 27987561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
    Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
    ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
    Zimmer L
    Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of pre-clinical PET imaging for drug development].
    Tsukada H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Drug Discovery and Development Using Molecular Imaging (ADDMI): an Interest Group of the World Molecular Imaging Society and an Inaugural Session on Positron Emission Tomography (PET).
    Patel S; Schmidt K; Hesterman J; Hoppin J
    Mol Imaging Biol; 2017 Jun; 19(3):348-356. PubMed ID: 28417265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET as a Translational Tool in Drug Development for Neuroscience Compounds.
    Varrone A; Bundgaard C; Bang-Andersen B
    Clin Pharmacol Ther; 2022 Apr; 111(4):774-785. PubMed ID: 35201613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational PET imaging research.
    Hargreaves RJ; Rabiner EA
    Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery.
    Pulagam KR; Gómez-Vallejo V; Llop J; Rejc L
    Curr Med Chem; 2020; 27(4):501-522. PubMed ID: 31142249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has molecular and cellular imaging enhanced drug discovery and drug development?
    Niu G; Chen X
    Drugs R D; 2008; 9(6):351-68. PubMed ID: 18989988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small animal PET in preclinical studies: opportunities and challenges.
    Riemann B; Schäfers KP; Schober O; Schäfers M
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of non-FDG-PET in the management of head and neck cancer.
    Heuveling DA; de Bree R; van Dongen GA
    Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive imaging in experimental medicine for drug development.
    Matthews PM; Rabiner I; Gunn R
    Curr Opin Pharmacol; 2011 Oct; 11(5):501-7. PubMed ID: 21570913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of carbon-11 labelled PET tracers-radiochemical and technological challenges in a historic perspective.
    Antoni G
    J Labelled Comp Radiopharm; 2015 Mar; 58(3):65-72. PubMed ID: 25684179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.